There are already two COVID-19 vaccines in the market, and they are being distributed across the different states at different speeds. However, experts in the world are now talking about the brand-new entry to the field: the COVID-19 vaccine from Johnson & Johnson. Although slightly different from the vaccination shots from Pfizer and Moderna, the Johnson & Johnson vaccine announced last Friday is promising in many other aspects. Even though the vaccine offers only 70% resistance against the virus, it provides extra convenience since it needs a single-shot administration. It means citizens don’t have to wait till the second shot to stay safe from the Coronavirus strands.
On the announcement Johnson & Johnson made on Friday, the company said that the new vaccine could play an essential role in reducing infections and hospitalizations in the long run. More importantly, the vaccine is said to work against the South African mutation, called the B.1.351. This is a bold claim, considering that the South African mutation is the only one to have shown some kind of resistance towards the vaccines and drugs used against COVID-19 at this point. There are also some extra advantages when storing the shots for later use.
Unlike the Pfizer and Moderna vaccines that require extreme refrigeration, the Johnson & Johnson vaccine will stay unaffected at normal refrigeration temperatures. This characteristic means the administration will have fewer logistics issues while keeping and transporting the vaccine. Among the experts who have praised the vaccine from J&J is Dr Anthony Fauci. Dr Fauci told CNN that an inexpensive and easy-to-store vaccine that can accomplish its effects in a single shot is a better choice than the mRNA vaccines from Pfizer or Moderna.
Dr Fauci says this even after considering that the J&J vaccine has lower resistance to the strands of viruses than the others. For reference, both Pfizer and Moderna have achieved an impressive 95% resistance from the virus for their vaccine doses. Compared to this figure, the 66% global resistance of the new vaccine isn’t an impeccable figure, per se. However, as Dr Fauci has said, the advantages on the convenience side easily outweigh the disadvantage of the low resistance.
We should also consider that the number of Coronavirus cases based on the South African mutation is rising. In this scenario, having an effective vaccine like this can improve the country’s overall preparation when it comes to protecting the citizens from future infections from spreading. On the governmental side, the US administration has already ordered about 100 million doses from Johnson & Johnson, meaning that they would be part of the vaccination streaks soon.
However, this will be based on the final decision from the EUA from the FDA. In light of the existing orders placed by the US governments and the recommendations from experts including Dr Fauci, it’s clear that the Johnson & Johnson vaccine would quickly become a trusted choice for other countries, especially those dealing with the new strains.